BeiGene, Ltd.
ONC
$230.98
$2.841.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -139.70M | -150.92M | -120.41M | -251.15M | -334.79M |
| Total Depreciation and Amortization | 167.03M | -46.90M | 23.75M | 24.11M | 83.94M |
| Total Amortization of Deferred Charges | 4.73M | -2.31M | 1.18M | 1.18M | 3.74M |
| Total Other Non-Cash Items | 236.71M | 75.61M | 113.30M | 72.64M | 221.97M |
| Change in Net Operating Assets | -157.17M | 263.35M | -113.41M | -155.36M | -370.54M |
| Cash from Operations | 111.61M | 138.83M | -95.59M | -308.57M | -395.69M |
| Capital Expenditure | -87.76M | -151.68M | -109.95M | -156.58M | -125.13M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -159.55M | 159.14M | -1.08M | -53.25M | -213.01M |
| Cash from Investing | -247.32M | 7.46M | -111.03M | -209.83M | -338.15M |
| Total Debt Issued | 548.58M | 60.48M | 182.38M | 151.08M | 500.42M |
| Total Debt Repaid | -558.78M | -63.09M | -167.93M | -3.58M | -154.66M |
| Issuance of Common Stock | 3.85M | 160.29M | 5.56M | 14.79M | 1.15M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -14.49M | -- | -- | -- |
| Other Financing Activities | 22.20M | -161.18M | 3.00M | -- | 18.35M |
| Cash from Financing | 30.05M | -14.98M | 23.02M | 162.29M | 381.13M |
| Foreign Exchange rate Adjustments | -49.99M | 26.02M | -5.90M | -22.44M | -14.28M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -155.64M | 157.33M | -189.51M | -378.55M | -366.98M |